news

Skadden, Arps, Slate, Meagher & Flom has advised Hong Kong biotech startup Prenetics on its planned $459 million Nasdaq listing via a merger with special purpose acquisition company (SPAC) Artisan Acquisition, which was represented by Kirkland & Ellis.

The transaction values Prenetics at an enterprise value of $1.25 billion with a combined equity value of up to $1.7 billion, making Prenetics the first Hong Kong unicorn to become a publicly listed company.

The Skadden team was led by partners Jonathan Stone, Peter Huang, and Paloma Wang and Victor Hollender.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com.

Related Articles

Deals

Skadden, Jia Yuan, Freshies, KWM act on Midea’s $3.5 bln HK share offering

by Asian Legal Business《亚洲法律杂志》 |

Skadden, Arps, Slate, Meagher & Flom and Jia Yuan Law Offices are advising Chinese home appliance maker Midea Group on its HK$26.97 billion ($3.46 billion) share offering in Hong Kong, the city's largest listing in more than three years.

Deals

Skadden, STB advise on Timee’s $435mln Japan IPO

by Nimitt Dixit |

U.S. law firm Skadden, Arps, Slate, Meagher & Flom has guided Timee, Inc, a Japanese on-demand job platform, on its $435 million initial public offering and listing on the Tokyo Stock Exchange. Simpson Thacher & Bartlett advised the international managers on the deal.

Deals

Skadden, Latham act on $1.1 bln Japan outbound pharma deal

by Asian Legal Business《亚洲法律杂志》 |

Skadden, Arps, Slate, Meagher & Flom has advised Japan's Otsuka Pharmaceutical on its $1.1 billion agreement to acquire Boston-based Jnana Therapeutics, which was represented by Latham & Watkins.